Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07085923. HopeStage can help you review the study, but cannot decide medical eligibility.
RecruitingNCT07085923
Norwegian Mental Illness Heart Health Study
This study is recruiting. It focuses on schizophrenia and currently lists participation information in Norway.
SchizophreniaOtherFrom 25 Years to 70 Years
Key information made simple
This study is comparing Lifestyle Intervention with Control for people with severe mental illness. Participants receive Lifestyle Intervention or Control and complete study visits and assessments. Some participants may receive Control instead of the study treatment, and direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a university, with sites including Department for nutrition science, Domus Medica, University of Oslo. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis and having a stable enough treatment background for the study, while common reasons not to take part include active substance or alcohol problems that could affect the results and pregnancy or breastfeeding. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Madeleine Elisabeth Angelsen
- Sponsor type
- Unknown or unclear
- Main activity
- behavioral or lifestyle intervention
- Intervention
- Not available
- Time commitment
- multiple visits or assessments
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Recruiting
- Source
- Official registry link
Key study information
- Official title
- Norwegian Mental Illness Heart Health Study
- Condition
- Cardio Vascular Disease; Metabolic Syndrome (MetS); Severe Mental Disorder; Schizophrenia and Schizophrenia Spectrum Psychosis; Bipolar Disease Type I; Overweight and/or Obesity; CVD Risk Factors; Severe Mental Illness
- Study status
- Recruiting
- Sponsor / lead affiliation
- Madeleine Elisabeth Angelsen
- Location / country
- Norway
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07085923
Why this study may matter
This study may matter because it adds public evidence around schizophrenia. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help improve understanding of your condition.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Norway.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Norwegian Mental Illness Heart Health Study
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07085923
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Norwegian Mental Illness Heart Health Study?
This study is exploring behavioral or lifestyle intervention for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Madeleine Elisabeth Angelsen. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve behavioral or lifestyle intervention, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me